Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research capabilities Joint venture will...
16% Increase in Quarter-over-Quarter Revenue; Quarterly Expense Reduction of 17% TORONTO, May 30, 2019 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“CB2” or the “Company”), a leading technology company...
Exclusive Interview with CB2Insights Co-Founder and CEO Prad Sekar CB2 Insights (CSE: CBII) (OTC: CBIIF) is using data and proprietary technology to drive the integration of medical cannabis into...